Amicus Therapeutics: Q2 Earnings Snapshot
In this article:
PHILADELPHIA (AP) — PHILADELPHIA (AP) — Amicus Therapeutics Inc. (FOLD) on Tuesday reported a loss of $43.2 million in its second quarter.
On a per-share basis, the Philadelphia-based company said it had a loss of 15 cents.
The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.
The pharmaceutical company posted revenue of $94.5 million in the period, which beat Street forecasts. Five analysts surveyed by Zacks expected $89.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOLD at https://www.zacks.com/ap/FOLD
